| | |

P16 Test May Improve Diagnostic Accuracy for Mesothelioma

ByAlex Strauss
diagnostic accuracy for mesothelioma

Scientists in the UK say testing for a tumor suppressor protein called p16 can improve diagnostic accuracy for mesothelioma. It may also help predict which patients are likely to have the best treatment response.

The p16 protein is encoded by the CDKN2A gene. Many people with mesothelioma are missing this gene. 

Previous studies show a lack of p16 may be linked to lower cancer survival. Now, researchers in Manchester say it should be added to routine tests to improve prognostic and diagnostic accuracy for mesothelioma.

The Challenge of Diagnostic Accuracy for Mesothelioma

It is not easy to diagnose mesothelioma. There is no single test that can show if a person has this cancer. Diagnosis usually involves blood tests, imaging studies, and a biopsy. Doctors also need to know if a person has been exposed to asbestos. Asbestos is the main cause of mesothelioma. 

The more tests a person has, the longer it takes to get an accurate diagnosis. Even with all of the current tests, the diagnosis can still be wrong. It is easy to mistake mesothelioma for other conditions. In the meantime, a mesothelioma tumor may be growing quickly. 

Anything that can improve diagnostic accuracy for mesothelioma is also likely to improve survival. 

How Does p16 Level Impact Mesothelioma?

P16 plays an important role in regulating the life cycle of cells. It slows down the progression from the protein-making phase to the DNA replicating phase. Mesothelioma can occur when DNA does not replicate properly. P16 helps keep that from happening by forcing cells to slow down. 

The new study took place at Wythenshawe Hospital at Manchester University. The hospital uses an advanced test called fluorescence in situ hybridization (FISH) to test for p16 deletion.

Researchers analyzed p16 FISH tests from 216 mesothelioma patients. They wanted to evaluate the test’s diagnostic accuracy for mesothelioma. They also hoped to see how it relates to mesothelioma progression and survival. 

Sixty percent of the mesothelioma samples were missing p16. Even more important, there were no false positive results. P16 deletion was only found in people with mesothelioma. The patients who were missing p16 had a much shorter survival than other mesothelioma patients (285 days versus 339 days).

The researchers conclude that p16 FISH testing can improve diagnostic accuracy for mesothelioma. Their results mirror what previous p16 studies have also found.

“In this study, 60% of mesotheliomas harbour a homozygous deletion of CDKN2A and can be accurately, reliably and efficiently identified by p16 FISH testing,” writes lead author Kelly Marshall. “This test can be embedded within routine practice in mesothelioma pathways to enhance diagnostic accuracy.”

P16 deletion or mutation is linked to poor survival in melanoma and cervical cancer, too.

Source:

Marshall, K, et al, “Homozygous deletion of CDKN2A in malignant mesothelioma: Diagnostic utility, patient characteristics and survival in a UK mesothelioma centre”, November 5, 2020, Lung Cancer, https://www.lungcancerjournal.info/article/S0169-5002(20)30673-5/fulltext

Similar Posts

Mesothelioma Still Rising Despite Ban in Ireland
|

Mesothelioma Still Rising Despite Ban in Ireland

ByAlex Strauss

A study in Ireland confirms that it can take many years for a ban on asbestos to have a measurable impact on a country’s rates of malignant mesothelioma. Mesothelioma is the most serious of a list of diseases – including lung cancer, pleural plaques, asbestosis, and others – linked with exposure to asbestos dust. Affecting the linings around the lungs and other organs, mesothelioma is often resistant to most cancer treatments and may be fatal within a year of diagnosis. According to the International Ban Asbestos Secretariat, Ireland is one of 55 countries that have enacted some type of asbestos ban. However, although Ireland banned asbestos in 2000, a new study published in Cancer Epidemiology shows that incidence of the…

Website Aims to Protect Homeowners from Mesothelioma
|

Website Aims to Protect Homeowners from Mesothelioma

ByAlex Strauss

Australia’s Cancer Council is trying to educate home renovators about their risk for mesothelioma with a new e-learning course. Australia has one of the highest per capita rates of mesothelioma in the world, largely because of several asbestos mining operations that were once located there. Although asbestos has been banned from building products in Australia since 1989, asbestos-linked diseases like mesothelioma, lung cancer, and asbestosis continue to pose a serious health concern. While mesothelioma has traditionally occurred among people exposed to asbestos on the job, Australia is now bracing for another “wave” of mesothelioma victims among homeowners who encounter asbestos while doing their own renovation projects. Cancer Council Australia has launched “kNOw asbestos in your home” in an effort to…

Mesothelioma Nurses Ready for New Cases in Australia
| | |

Mesothelioma Nurses Ready for New Cases in Australia

ByAlex Strauss

Australia is bracing for an expected new wave of mesothelioma cases in the next decade and the Lung Foundation of Australia is taking action now to get ready. The Foundation has paid for ten nurses from around the country to receive specialized training in helping patients and families cope with mesothelioma. The nurses, who have recently completed the training, are now equipped to lead treatment planning for these complex cancer patients and to help other nurses do the same. Pleural mesothelioma is an aggressive cancer that occurs in the lining around the lungs. It is caused by exposure to asbestos dust, a toxin that was once alarmingly prevalent in Australia where it was mined and heavily used in construction. Because…

Mesothelioma Blood Test May Be Possible
|

Mesothelioma Blood Test May Be Possible

ByAlex Strauss

An international team of researchers is studying the proteins found on the surface of cancer cells in an effort to improve mesothelioma diagnosis. The team, made up of scientists from the US, Switzerland, Italy and Chile, has just published their findings on a new kind of test to identify protein-derived mesothelioma biomarkers in blood serum. Mesothelioma is an aggressive cancer of the membranes around organs. Because the most common mesothelioma biomarker, mesothelin, is also overproduced by other kinds of cancer cells, it has only limited diagnostic value. A test to identify a set of proteins produced specifically by mesothelioma cells could greatly improve diagnostic accuracy. Led by Ferdinando Cerciello and Bernd Wollscheid of the Institute of Molecular Systems Biology in…

Spanish Mesothelioma Deaths Likely to Continue for Decades
| |

Spanish Mesothelioma Deaths Likely to Continue for Decades

ByAlex Strauss

New research in Spain suggests that mesothelioma deaths will continue in the country until the “last surviving member” of the group of people exposed to occupational asbestos succumbs to the disease. Like many countries, Spain used asbestos heavily in the first half of the 20th century, especially in construction, where the mineral was prized for its durability, low cost, and resistance to fire and corrosion.  Asbestos was banned in Spain in 2002. Observing that more than 2.5 million metric tons of asbestos were imported into Spain from 1906 to 2002, researchers say deaths from mesothelioma have risen steadily. Between 1976 and 1980, a total of 491 Spanish people died of mesothelioma. By the 5-year period from 2006 to 2010, that…

Needle Biopsy “Simple, Safe & Accurate” for Mesothelioma
| |

Needle Biopsy “Simple, Safe & Accurate” for Mesothelioma

ByAlex Strauss

Mesothelioma researchers in China say a biopsy method that involves a single skin puncture can produce good diagnostic results for mesothelioma patients with little pain or risk. The study focused on percutaneous (through the skin) biopsy in patients who had unexplained fluid buildup or swelling in their abdomens. Abdominal distension and fluid buildup (called ascites) can be signs of peritoneal mesothelioma, a rare but aggressive cancer of the abdominal lining caused by exposure to asbestos. Peritoneal mesothelioma accounts for less than 30% of all mesothelioma cases. Because the symptoms may be vague and often develop many decades after asbestos exposure, peritoneal mesothelioma can be especially challenging to diagnose.  Misdiagnosis and under-diagnosis are not uncommon. In the newest study on percutaneous…